Health Care [ 11/12 ] | Health Care Equipment & Supplies [ 66/73 ]
NYSE MKT | Common Stock
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally.
It offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis such as sepsis; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes.
VolitionRx Limited is based in Henderson, Nevada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 12, 25 | -0.06 Increased by +39.70% | -0.04 Decreased by -34.00% |
| Mar 24, 25 | -0.06 Increased by +45.45% | -0.05 Decreased by -12.57% |
| Nov 12, 24 | -0.07 Increased by +36.36% | -0.07 |
| Aug 14, 24 | -0.08 Increased by +42.86% | -0.09 Increased by +11.11% |
| May 13, 24 | -0.10 Increased by +33.33% | -0.11 Increased by +9.09% |
| Mar 25, 24 | -0.11 Increased by +15.38% | -0.11 |
| Nov 14, 23 | -0.11 Increased by +21.43% | -0.13 Increased by +15.38% |
| Aug 14, 23 | -0.14 Increased by 0.00% | -0.15 Increased by +6.67% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 246.38 K Increased by +43.64% | -5.42 M Increased by +35.18% | Decreased by -2.20 K% Increased by +54.87% |
| Dec 31, 24 | 191.66 K Decreased by -21.44% | -5.79 M Increased by +33.40% | Decreased by -3.02 K% Increased by +15.22% |
| Sep 30, 24 | 474.52 K Increased by +187.22% | -5.82 M Increased by +30.45% | Decreased by -1.23 K% Increased by +75.79% |
| Jun 30, 24 | 395.80 K Increased by +82.98% | -6.99 M Increased by +26.24% | Decreased by -1.76 K% Increased by +59.69% |
| Mar 31, 24 | 171.53 K Increased by +14.50% | -8.37 M Increased by +4.69% | Decreased by -4.88 K% Increased by +16.77% |
| Dec 31, 23 | 243.97 K Increased by +103.79% | -8.70 M Decreased by -20.11% | Decreased by -3.57 K% Increased by +41.06% |
| Sep 30, 23 | 165.21 K Increased by +405.02% | -8.37 M Decreased by -8.10% | Decreased by -5.07 K% Increased by +78.59% |
| Jun 30, 23 | 216.31 K Increased by +444.15% | -9.47 M Decreased by -23.81% | Decreased by -4.38 K% Increased by +77.25% |